Anti-Human ULBP6 Antibody (23ME-01473) from ProteoGenix; catalogue ARO-A22666; research use only.
Know who made it. See the evidence. Buy through one marketplace.
The Anti-Human ULBP6 Antibody (23ME-01473) is a highly specific and potent antibody designed to target the ULBP6 protein in human cells. This antibody is a valuable tool for researchers in the field of biotechnology, as it provides a reliable and efficient means of studying the biological function of ULBP6.
ULBP6, also known as UL16-binding protein 6, is a cell surface protein that plays a crucial role in the immune response. It belongs to the ULBP family of proteins, which are involved in the recognition and elimination of infected or abnormal cells by the immune system. ULBP6 is primarily expressed on the surface of tumor cells, making it a potential target for cancer immunotherapy.
The Anti-Human ULBP6 Antibody (23ME-01473) is primarily used in research applications to study the role of ULBP6 in various biological processes. It can be used for Western blotting, immunofluorescence, and immunohistochemistry experiments to detect and quantify ULBP6 expression in different cell types and tissues. This antibody is also suitable for flow cytometry analysis, which allows for the identification and characterization of cells expressing ULBP6.
The Anti-Human ULBP6 Antibody (23ME-01473) has been successfully used in various research studies to investigate the function of ULBP6 in different disease states. For example, it has been used to study the role of ULBP6 in tumor growth and metastasis, as well as its potential as a therapeutic target for cancer treatment. This antibody has also been used to examine the involvement of ULBP6 in autoimmune diseases and to evaluate its potential as a biomarker for disease diagnosis and prognosis.
In addition to its research applications, the Anti-Human ULBP6 Antibody (23ME-01473) can also be used in the development of new immunotherapies targeting ULBP6. By specifically binding to ULBP6, this antibody can potentially block its interaction with immune cells, leading to enhanced anti-tumor immune responses.
Overall, the Anti-Human ULBP6 Antibody (23ME-01473) is a valuable tool for researchers studying the role of ULBP6 in various biological processes and diseases. Its high specificity and potency make it a reliable choice for experiments, and its potential for therapeutic development adds to its value. Order now and advance your research in the field of biotechnology.
ProteoGenix catalogue number ARO-A22666. For research use only.
Target: ULBP6; Clonality: Monoclonal Antibody; Reactivity: Human; Applications: ELISA, Block.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | Block |
|---|---|---|---|---|---|---|---|---|---|
| Human |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
